Don't Buy It Yet: The AI Tool Everyone Is Pre-Ordering

It looks genuinely impressive. The demo video is beautiful. The waitlist is forty thousand people deep and the founder's post is being shared by everyone you follow. Before you add yourself to that list, three honest questions.

This is a preview, not a review — the tool isn't fully out yet. Which is exactly why we should be careful.

Question one: what has actually shipped?

There is a large and important difference between what a tool promises and what it currently does. Demo videos show the promise: the polished, best-case, everything-works version. The waitlist is selling you that video.

Before you get attached, separate the two. What can this tool do today, that you could verify with your own hands? And what is described in the future tense — "will," "soon," "coming"? A product that is mostly future tense is a pitch, not a product. Pitches are allowed to be exciting. Your money should wait for the present tense.

Question two: do you have the problem it solves?

This is the question that saves the most money, and it's the one hype is designed to make you skip. Impressive and necessary are not the same thing.

A tool can be genuinely well-built and still be wrong for you, because you don't have the problem it solves. The demo makes the problem look universal. It usually isn't. Ask yourself, specifically: what am I doing right now, this week, that this tool would replace? If you can name the task and it's a real recurring pain, good — keep reading. If you're reaching, and the honest answer is "nothing yet, but it looks useful," that's not a reason to buy. That's a reason to bookmark.

Question three: what would you be paying for on day one?

Early access usually means early-stage. That can mean bugs, missing features, changing prices, and a product that looks different in three months. Sometimes getting in early is worth it. Often you're paying full price to be an unpaid tester.

There's rarely a penalty for waiting. The tool will still exist next quarter, probably cheaper, definitely more stable, and by then real users — not the launch-day chorus — will have told you whether it holds up.

What would change my mind

I'm not against this tool. I'm against buying it now, on a demo and a waitlist. Here's the specific signal I'd wait for: independent people, who don't benefit from your purchase, using it on their real work and reporting that it held up. Not the founder. Not the affiliates. Actual users, a few months in.

When that arrives, revisit it. If the problem it solves is one you genuinely have, it may well be worth every cent.

Why the waitlist itself is the product

Here's something worth seeing clearly: the waitlist is not a neutral sign-up sheet. It's a marketing instrument, and a very effective one. A long waitlist creates the impression of consensus — forty thousand people can't be wrong — and consensus is persuasive even when it's manufactured. But a waitlist measures interest, not quality. It tells you a lot of people watched a good demo. It tells you nothing about whether the tool works on real, messy, day-three-of-a-busy-week tasks.

The scarcity is doing the same work. "Limited early access" is designed to convert curiosity into urgency, because urgency short-circuits the calm questions we just walked through. When you feel the pull to sign up right now so you don't miss out, that feeling is the product working as designed. It's not information about the tool. It's a lever on you.

None of this makes the founders villains. It's simply how launches work now. But knowing the mechanism lets you step outside it. A tool that's genuinely good will still be good after the launch urgency fades — and you'll be able to judge it on evidence instead of atmosphere.

The one time buying early is actually worth it

To be fair, "wait" is not an absolute rule, and I'd be overcorrecting if I pretended it were. There is a situation where getting in early makes sense, and it's worth naming so you can tell it apart from the hype.

Buy early when you already have the exact problem the tool solves, today, and you're currently solving it in a way that genuinely costs you — time, money, or sanity. If you're paying for three clumsy tools to do what this one promises to do cleanly, and the demo shows the specific thing you're struggling with actually working, then early access might be worth the risk of a few bugs. You're not buying the hype. You're buying relief from a pain you can already feel.

The test is simple. Can you describe the problem this solves without using the tool's own marketing language? "I lose two hours a week manually doing X" is a real problem. "It'll help me stay ahead of AI" is a slogan you absorbed from the launch. The first is a reason to consider buying early. The second is the reason the waitlist exists.

If you have the pain, the specific pain, in the present tense — proceed with open eyes. Otherwise, wait.

The verdict: wait

Skepticism early is not cynicism. It's how you avoid a drawer full of subscriptions to things that looked revolutionary for a week.

Before you buy another tool, fix the workflow — and before you join another waitlist, make sure you can name the exact problem you're hoping it will solve. If you can't, you don't need the tool. You need a quiet afternoon and an honest look at where your time actually goes.